FENC
Fennec Pharmaceuticals Inc
10.60$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -146.2% | |
| – | +6.2% | +124.1% | +1,197.5% | +56.8% | +21.3% | -20.5% | -92.1% | -14.6% | – | – | – | – | – | – | – | – | – | – | – | +528.1% | -96.0% | +831.3% | +92.6% | +234.1% | -89.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -90.0% | +30.4% | -73.3% | +620.7% | -84.5% | +534.0% | +146.7% | +20.3% | +46.0% | +4.7% | +43.9% | +5.1% | +26.9% | -5.5% | +39.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -419.3% | – | +265.2% | -19.3% | +59.7% | -6.7% | +40.5% | +9.0% | – | – | – | |
| – | -182.1% | – | -257.7% | – | +65.7% | +111.6% | -215.9% | – | -1,509.7% | – | -169.8% | – | -230.4% | – | -152.5% | – | +10,030.0% | -87.0% | +331.1% | -216.5% | – | – | – | – | – | |
| – | +926.1% | -9.9% | -76.6% | +122.3% | -34.2% | -95.1% | +1,360.0% | -79.5% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | +900.1% | +1,693.6% | – | -238.3% | -82.3% | – | -106.4% | -80.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +49.2% | -78.8% | +927.8% | +447.7% | -91.7% | -103.0% | – | -100.0% | +2,325.0% | -59.8% | +125.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +304.6% | -75.2% | -360.2% | +49.8% | |
| – | +857.0% | -100.3% | – | +996.9% | -67.6% | -23.9% | +294.4% | -100.0% | – | – | -64.3% | – | – | +49.2% | -78.8% | +927.8% | +447.7% | -91.6% | -103.0% | – | -84.6% | +316.5% | -68.0% | -305.1% | – | |
| – | +37,893.1% | -198.0% | – | +499.4% | -148.3% | – | – | -203.0% | – | – | -112.4% | – | – | – | -312.0% | – | +715.5% | -122.5% | – | – | -155.4% | – | -492.9% | – | -24.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -146.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.